184 related articles for article (PubMed ID: 17443573)
1. Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients.
Hodson EM; Jones CA; Strippoli GF; Webster AC; Craig JC
Cochrane Database Syst Rev; 2007 Apr; (2):CD005129. PubMed ID: 17443573
[TBL] [Abstract][Full Text] [Related]
2. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
Hodson EM; Barclay PG; Craig JC; Jones C; Kable K; Strippoli GF; Vimalachandra D; Webster AC
Cochrane Database Syst Rev; 2005 Oct; (4):CD003774. PubMed ID: 16235341
[TBL] [Abstract][Full Text] [Related]
3. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
Hodson EM; Ladhani M; Webster AC; Strippoli GF; Craig JC
Cochrane Database Syst Rev; 2013 Feb; (2):CD003774. PubMed ID: 23450543
[TBL] [Abstract][Full Text] [Related]
4. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
Hodson EM; Craig JC; Strippoli GF; Webster AC
Cochrane Database Syst Rev; 2008 Apr; (2):CD003774. PubMed ID: 18425894
[TBL] [Abstract][Full Text] [Related]
5. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
Vernooij RW; Michael M; Ladhani M; Webster AC; Strippoli GF; Craig JC; Hodson EM
Cochrane Database Syst Rev; 2024 May; 5(5):CD003774. PubMed ID: 38700045
[TBL] [Abstract][Full Text] [Related]
6. Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients.
Strippoli GF; Hodson EM; Jones CJ; Craig JC
Cochrane Database Syst Rev; 2006 Jan; (1):CD005133. PubMed ID: 16437521
[TBL] [Abstract][Full Text] [Related]
7. Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients.
Owers DS; Webster AC; Strippoli GF; Kable K; Hodson EM
Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD005133. PubMed ID: 23450558
[TBL] [Abstract][Full Text] [Related]
8. Preemptive treatment for cytomegalovirus viremia to prevent cytomegalovirus disease in solid organ transplant recipients.
Strippoli GF; Hodson EM; Jones C; Craig JC
Transplantation; 2006 Jan; 81(2):139-45. PubMed ID: 16436954
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients.
Kalil AC; Levitsky J; Lyden E; Stoner J; Freifeld AG
Ann Intern Med; 2005 Dec; 143(12):870-80. PubMed ID: 16365468
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive T-cell antibody induction for heart transplant recipients.
Penninga L; Møller CH; Gustafsson F; Gluud C; Steinbrüchel DA
Cochrane Database Syst Rev; 2013 Dec; (12):CD008842. PubMed ID: 24297433
[TBL] [Abstract][Full Text] [Related]
11. WITHDRAWN: Cytomegalovirus prophylaxis with antiviral agents for solid organ transplantation.
Couchoud-Heyer C
Cochrane Database Syst Rev; 2007 Jul; 1998(4):CD001320. PubMed ID: 17636667
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 2 receptor antagonists for kidney transplant recipients.
Webster AC; Ruster LP; McGee R; Matheson SL; Higgins GY; Willis NS; Chapman JR; Craig JC
Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD003897. PubMed ID: 20091551
[TBL] [Abstract][Full Text] [Related]
13. Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials.
Hodson EM; Jones CA; Webster AC; Strippoli GF; Barclay PG; Kable K; Vimalachandra D; Craig JC
Lancet; 2005 Jun 18-24; 365(9477):2105-15. PubMed ID: 15964447
[TBL] [Abstract][Full Text] [Related]
14. CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis.
Bonaros N; Mayer B; Schachner T; Laufer G; Kocher A
Clin Transplant; 2008; 22(1):89-97. PubMed ID: 18217909
[TBL] [Abstract][Full Text] [Related]
15. Anti-herpesvirus prophylaxis, pre-emptive treatment or no treatment in adults undergoing allogeneic transplant for haematological disease: systematic review and meta-analysis.
Beyar-Katz O; Bitterman R; Zuckerman T; Ofran Y; Yahav D; Paul M
Clin Microbiol Infect; 2020 Feb; 26(2):189-198. PubMed ID: 31536817
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic prophylaxis for preventing post solid organ transplant tuberculosis.
Adamu B; Abdu A; Abba AA; Borodo MM; Tleyjeh IM
Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD008597. PubMed ID: 24590589
[TBL] [Abstract][Full Text] [Related]
17. Interventions for preventing bone disease in kidney transplant recipients.
Palmer SC; McGregor DO; Strippoli GF
Cochrane Database Syst Rev; 2007 Jul; (3):CD005015. PubMed ID: 17636784
[TBL] [Abstract][Full Text] [Related]
18. Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection.
Xia Y; Luo H; Liu JP; Gluud C
Cochrane Database Syst Rev; 2013 Apr; (4):CD009004. PubMed ID: 23633363
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 2 receptor antagonists for kidney transplant recipients.
Webster AC; Playford EG; Higgins G; Chapman JR; Craig J
Cochrane Database Syst Rev; 2004; (1):CD003897. PubMed ID: 14974043
[TBL] [Abstract][Full Text] [Related]
20. Antifungal agents for preventing fungal infections in solid organ transplant recipients.
Playford EG; Webster AC; Sorell TC; Craig JC
Cochrane Database Syst Rev; 2004; (3):CD004291. PubMed ID: 15266524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
